Диссертация (1139900), страница 20
Текст из файла (страница 20)
359. – P. 657-659.145. Changing clinical presentation and survival in HIV-associated tuberculosis afterhighly active antiretroviral therapy / E. Girardi [et al.] // J. Acquir. Immune Defic.Syndr. – 2001. – Vol. 26, № 4. – P. 326-331.146. Clinical and operational value of the extensively drug-resistant tuberculosisdefinition / G.
Migliori [et al.] // Eur Respir J – 2007. – Vol. 30. – P. 623-626.147. Clinical characteristics of IRIS syndrome in patients with HIV and tuberculosis /C. Michailidis [et al.] // Antivir. Ther. – 2005. – Vol. 10. – P. 417-422.148. Comprehensive treatment of extensively drugresistant tuberculosis / C.D. Mitnick[et al.] // N Engl J Med. – 2008. – Vol. 359. – P. 563-574.149. Correlation between CD4 lymphocytes and viral load in patients with HIV andtuberculosis / F.L.
Lado Lado [et al.] // An. Med. Interna. – 2001. – Vol. 18, № 12.– P. 624-628.126150. Deaths from tuberculosis in Sub-Saharan African countries with a high prevalenceof HIV-1 / A.D. Harries [et al.] // The Lancet. – 2001. – Vol. 357, № 9267. –P. 1519-1529.151. Demissie, M. Sensitivity to anti-tuberculosis drugs in HIV positive and negativeTB patients in Addis-Ababa / M. Demissie, E. Lemma, M.
Gebeyehu // Int. J.Tuberc. Lung Dis. – 2001. – Vol. 5, № 11, suppl. l. – P. 85.152. Determinants of Immune Reconstitution Inflammatory Syndrome in HIV Type 1 –Infected Patients with Tuberculosis after Initiation of Antiretroviral Therapy /G. Breton [et al.] // Clinical Infectious Diseases. – 2004. – № 39. – P. 1709-1712.153. Diagbouga, S. Alteration in CD29 (high) CD4(+) lymphocyte subset is a commonfeature of early HIV disease and of active tuberculosis / S. Diagbouga, J.P.
Chiron// Scand. J. Immunol. – 2001. – Vol. 53, № l. – P. 79-84.154. Driver, C.R. Relapse in persons treated for drug-susceptible tuberculosis in apopulation with high coinfection with human immunodeficiency virus in NewYork City / C.R. Driver, S.S. Munsiff // Clin. Infect. Dis. – 2001. – Vol. 33, № 10.– P. 1762-1769.155. Effect of simultaneous use of highly active antiretroviral therapy on survival ofHIV patients with tuberculosis / M. Velasco [et al.] // J. Acquir. Immune. Defic.Syndr. – 2009.
– Vol. 50, № 2. – P. 148-152.156. Epidemiology of extrapulmonary tuberculosis among persons with AIDS in theUnited States / M.B. Smith [et al.] // Arch. Pathol. Lab. Med. – 2000. – Vol. 124,№ 9. – P. 1267-1274.157. European guidelines for the clinical management and treatment of HIV-infectedadults in Europe / The EACS Euroguidelines Group // AIDS. – 2003. – Vol. 17,Suppl.
– P. S3-S26.158. Extensively drug-resistant tuberculosis as a cause of death in patients co-infectedwith tuberculosis in a rural area of South Africa / N.R. Gandhi [et al.] // Lancet. –2006. – Vol. 368. – P. 1575-1580.127159. Furrer, H. Systemic inflammatory reaction after starting highly active antiretroviraltherapy in AIDS patients treated for extrapulmonary tuberculosis / H. Furrer,R. Malinverni // American Journal of Medicine. – 1999. – Vol. 106.
– P. 371-372.160. HIV-coinfection in multidrug-resistant- and extensively drugresistant tuberculosisresults in high early mortalitу / N.R. Gandhi [et al.] // Am Respir Crit Care Med. –2010. – Vol. 181. – P. 80-86.161. Immune reconstitution and «unmasking» of tuberculosis during antiretroviraltherapy / S.D. Lawn [et al.] // Am. J. Respir. Crit. Care.Med. – 2008. – Vol.
177. –P. 680-685.162. Immune reconstitution inflammatory syndrome in HIV-infected patients receivingantiretroviral therapy: pathogenesis, clinical manifestations and management /D.J. Dhasmana [et al.] // Drugs. – 2008. – Vol. 68. – P. 191-208.163. Immune reconstitution inflammatory syndrome (IRIS): review of commoninfectious manifestations and treat-ment options [Electronic resource] / M. David,D.F. Willem, V. Annelies, F.
Charles // AIDS Research and Therapy. – 2007. –P. 4-9. – Режим доступа: www. aidsrestherapy.164. Immune reconstitution in severely immunocompromised patients initiatingHAART – the critical first months / C. Hoffmann [et al.] // 7th Deutscher AIDSKongress. – Essen, 1999.
– P. F1088.165. Immune reconstitution syndrome in patient streated for HIV and tuberculosis inRio de Janeiro / F.C. Serra [et al.] // Braz. J. Infect. Dis. – 2007. – Vol. 11, № 5. –P. 462-465.166. Immune restoration disease after the treatment of immunodeficient HIV-infectedpatients with HAART / M.A. French [et al.] // HIV Med. – 2000. – № 1. –P. 107-115.167. Immunopathology as a result of highly active antiretroviral therapy in HIV-1infected patients / N.A. Foudraine [et al.] // AIDS. – 1999. – Vol. 13, № 2. –P. 177-184.128168. Impact of tuberculosis on the course of HIV-infected patients with a high intialCD4 lymphocyte count / E. Manas [et al.] / Int.
J. Tuberc. Lung Dis. – 2004. –Vol. 8, № 4. – P. 445-450.169. Incidence and risk factors for immune reconstitution inflammatory syndromeduring highly active antiretroviral therapy / S.A. Shelburne [et al.] // AIDS. – 2005.– Vol. 19, № 4. – P. 399-406.170. Incidence of immune reconstitution syndrome in HIV/tuberculosis-coinfectedpatients after initiation of generic antiretroviral therapy in India / N. Kumarasamy[et al.] // Journal of Acquired Immune Deficiency Syndrome. – 2004. – Vol. 37,№ 5. – P. 1574-1576.171.
Lawn, S.D. Immune reconstitution disease associated with mycobacterialinfections in HIV-infected individuals receiving antiretrovirals / S.D. Lawn,L. Bekker, R.F. Miller // The Lancet Infectious Diseases. – 2005. – Vol. 5, № 6. –P. 361-373.172. Lee, M.P. Clinical manifestations of tuberculosis in HIV-infected patients /M.P. Lee, J.W. Chan // Respirology. – 2000. – Vol. 5, № 4. – P. 423-426.173. Malabsorption of rifampin and isoniazid in HIV-infected patients with and withouttuberculosis / P. Gurumurthy [et al.] // Clin.
Inf. Dis. – 2004. – Vol. 38, № 2. –P. 199-205.174. Multidrug- and extensively drug-resistant tuberculosis, Germany / B. Eker [et al.]// Emerg Infect Dis. – 2008. – Vol. 14. – P. 1700-1706.175. Multidrug-resistant tuberculosis: eight years of surveillance in France / J. Robert,D. Trystram, C. Truffot-Pernot, V. Jarlier // Eur Respir J. – 2003. – Vol. 22. –P. 833-837.176. Nagai, H.
Factors for the onset of and the exacerbation of tuberculosis. Theinfection and prognosis of tuberculosis among patients with immunodeficiency,especially HIV-infected patients / H. Nagai // Kekkaku. – 2003. – Vol. 78, № 1. –P. 45-49.177.
Nine months chemotherapy with INH and rifampicin for non cavitari pulmonarytuberculosis / Ch. Kino [et al.] // Kekkaku. – 1991. – Vol. 66, № 4. – P. 1-7.129178. Oral lesions and immune reconstitution syndrome in HIV+/AIDS patientsreceiving highly active antiretroviral therapy. Epidemiological evidence /L. Cepeda [et al.] // Med Oral Patol Oral Cir Bucal. – 2008. – Vol. 13, № 2. –P.
85-93.179. Pat Initial increase in blood CD4+ lymphocytes after HIV antiretroviral therapyreflects redistribution from lymphoid tissues / R.P. Bucy [et al.] // J. Clin. Invest. –1999. – № 103. – P. 1391-1398.180. Psyhological and socyal factors of patient with pulmonary tuberculosis / L. Yang[et al.] // J. Tuberc. And Respir. Disease. – 2003. – Vol. 26, № 11. – С. 704-707.181. Pulmonary tuberculosis in HIV-infected patients presenting with normal chestradiograph and negative sputum smear / F.
Palmieri [et al.] // Infection. – 2002. –Vol. 30, № 2. – P. 68-74.182. Radiological patterns in HIV-associated pulmonary tuberculosis: comparisonbetween HAART-treated andsnon-HAART-treated patients / E. Busi Rizzi [et al.]// Clin. Radiol. – 2003. – Vol. 58, № 6. – P. 469-473.183. Randomized placeboсоntrolled trialofprednisone for paradoxical tuberculosisassociated immunereconstitution inflammatory syndrome / G.
Meintjes [et al.] //AIDS (London, England). – 2010. – Vol. 24, № 15. – P. 2381-2390.184. Reconstitution inflammatory syndrome of tuberculosis among HIV-infectedpatients receiving antituberculous and antiretroviral therapy / W. Manosuthi [et al.]// J. Infect. – 2006. – Vol. 53, № 6. – P. 357-363.185. Risk factor analyses for immune reconstitution inflammatory syndrome in arandomized study of early vs. deferred ART during an opportunistic infection /P.M.
Grant [et al.] // PLoS One. – 2010. – Vol. 5, № 7. – P. e11416.186. Samuel, A. The immune reconstitution inflammatory syndrome / A. Samuel,I. Shelburne, J. Richard // AIDSRev. – 2003. – Vol. 5. – P. 67-79.187. Schiffer, J.T. Timing of antiretroviral therapy initiation in tuberculosis patientswith AIDS: a decision analysis / J.T. Schiffer, T.R. Sterling // J. AIDS. – 2007. –Vol. 44. – P. 229-234.130188. Selye, H. Thymus and adrenals in the response of the organism to inguries andintoxication / H. Selye // Brit.
J. Exper. Path. – 1936. – № 17. – P. 234-248.189. Shelburne, S.A. Immune reconstitution inflammatory syndrome: more answers,more questions / S.A. Shelburne, M. Montes, R.J. Hamil // Journal ofAntimicrobial Chemotherapy. – 2006. – № 57. – P. 167-170.190. Skamene, E. Genetic control of susceptibility to Micobacterial infections /E. Skamene // Rev.
Infect. Dis. – 1989. – Vol. 1, suppl. 2. – P. 394-399.191. Splenic tuberculosis in patients infected with human immunodeficiency virus /C. Salvado [et al.] // 8 th European conference on clinical aspects and treatment ofHIV-infections.
– Athens, 2001. – Vol. 177. – P. 319.192. The growing burden of tuberculosis: global trends and interactions with the HIVepidemic / E.L. Corbett [et al.] // Arch. Intern. Med. – 2003. – Vol. 163, № 9. –P. 1009-1021.193. The prevalence and risk of immune restoration disease in HIV-infected patientstreated with highly active antiretroviral therapy / D.J. Jevtovic [et al.] // 2005British HIV Association HIV Medicine. – 2005.
– № 6. – P. 140-143.194. The role of immune reconstitution inammatory syndrome in AIDSrelatedCryptococcus neoformans disease in the era of highly active antiretroviral therapy /S.A. Shelburne [et al.] // Clin. Infect. Dis. – 2005. – Vol. 40. – P. 1049-1052.195. Timing of initiation of antiretroviral drugs during tuberculosis therapy /S.S. Abdool Karim [et al.] // N. Engl. J.
Med. – 2010. – Vol. 362. – P. 697-706.196. Treatment outcome and laboratory confirmation of tuberculosis diagnosis inpatients with HIV/AIDS in Recife / M. Maruza [et al.] // Brazil. J. Bras. Pneumol.– 2008. – Vol. 34, № 6. – P. 394-403.197. Treatment outcomes and long-term survival in patients with extensively drugresistant tuberculosis / D.H. Kim [et al.] // Am J Respir Crit Care Med. – 2008. –Vol.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
